Careers

Three research scientists, including a nephrologist, awarded Nobel Prize in Medicine for work with how cells sense and adapt to oxygen

Announced on October 7th, the Nobel Prize in Medicine was jointly awarded to a trio of scientists, William G. Kaelin Jr., Peter J. Ratcliffe, and Gregg L. Semenza, for their work on “how cells sense and adapt to oxygen availability,” The New York Times reports.

These “investigators uncovered detailed genetic responses to changing oxygen levels that allow cells in the bodies of humans and other animals sense and respond to fluctuations, increasing and decreasing how much oxygen they receive.”

KidneyX award recipient receives HHS contract to provide hemodialysis systems for disaster response

The U.S. Department of Health and Human Services (HHS) has awarded a contract to a KidneyX award winner to provide hemodialysis systems in communities hit by natural disasters. The HHS Office of the Assistant Secretary for Preparedness and Response has stated it will be prepared to use the systems by the end of this year.

JASN Editor in Chief Josie Briggs, MD, Appointed Interim Executive Director of PCORI

On September 27th, the Patient-Centered Outcomes Research Institute (PCORI) announced the appointment of Josephine P. Briggs, MD, as PCORI’s Interim Executive Director, starting on November 1, 2019. Briggs will lead the organization during its search for a replacement for Joe Selby, MD, MPH, who announced plans to retire as Executive Director by year’s end. She will continue her work as JASN Editor-in-Chief during this time.

FDA approves first new treatment in 20 years to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure

The U.S. FDA has now approved INVOKANA® (canagliflozin) as the only type 2 diabetes (T2D) medicine indicated to treat diabetic kidney disease (DKD) and reduce the risk of hospitalization for heart failure in patients with T2D and DKD.  Approximately 1 in 3 patients with T2D also has DKD, which can ultimately lead to kidney failure. Once patients reach kidney failure, the average 5-year survival is less than 40%, largely due to cardiovascular-associated morbidity and mortality.

KHI Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies

With the aid of patients, care partners, and multiple academic, private, and public communities, the Kidney Health Initiative’s newly developed technology roadmap is catalyzing innovative approaches to kidney replacement therapy (KRT). The roadmap provides guidance for innovators and entrepreneurs who are working to redesign dialysis and provide better care for those with kidney disease.

New NephSAP Issue - "Chronic Kidney Disease and Progression"

NephSAP Volume 18, Number 4, September 2019

Chronic Kidney Disease and Progression

Interview with Dr. Michael Allon, editor-in-chief of Kidney360, on new ideas for the journal

allon-michael2_1.jpgKidney News Online (KNO) recently spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal began accepting manuscripts on October 1st, KNO wanted to learn more about the ideas behind the new journal.

 

Recent JAMA Study: Association Between Dialysis Facility Ownership and Access to Kidney Transplantation

A study released earlier this week in JAMA studied the question of whether dialysis facility ownership is associated with access to kidney transplantation.

Advancing Nephrology: Division Leaders Advise ASN

Asserting the value of nephrology

Physician productivity and compensation

Financial support of educational effort

Recruitment, retention, diversity and inclusion

Ensuring that Nephrology fellowship programs provide quality training in all aspects of kidney care

American Society of Transplantation issues statement on Tacrolimus shortage

According to the statement released by the American Society of Transplantation (AST):

Pages